Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

199.43B

Market cap199.43B

Price-Earnings ratio

9.85

Price-Earnings ratio9.85

Dividend yield

2.93%

Dividend yield2.93%

Average volume

12.10M

Average volume12.10M

High today

$44.37

High today$44.37

Low today

$42.68

Low today$42.68

Open price

$43.08

Open price$43.08

Volume

7.96M

Volume7.96M

52 Week high

$81.44

52 Week high$81.44

52 Week low

$35.12

52 Week low$35.12

NVO News

The Motley Fool 2h

Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success

The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the GLP-1 weight-loss space. These are newly i...

Bloomberg 5h

Denmark to Study Whether Wegovy Can Get More People Working

The new government in Novo Nordisk A/S ’s home country of Denmark wants to test whether weight-loss drugs can help get more people into work, adding a new econo...

TipRanks 14h

Major Insider Makes Bold Move in Prothena Stock

New insider activity at Prothena ( (PRTA) ) has taken place on June 3, 2026. Claim 55% Off TipRanks Unlock trusted, data-backed investing tools with TipRanks Pr...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

BBC 16h

Why Canadians can now get cheaper generic Ozempic - and Americans can't - BBC

...

Nasdaq 21h

Here's What I Think Is Really Going on With Novo Nordisk Stock

Key Points Novo Nordisk lost momentum in the GLP-1 market. The company's deep pipeline could allow it to bounce back. 10 stocks we like better than Novo Nord...

Simply Wall St 1d

Novo Nordisk Trial Updates Test Support For Obesity And Diabetes Valuation

Novo Nordisk (NYSE:NVO) is set to present new clinical data from its cardiometabolic portfolio at the 2026 American Diabetes Association Scientific Sessions. K...

Reuters 1d

Novo Nordisk launches Wegovy in UAE - Reuters

...

The Wall Street Journal 1d

Novo Nordisk Launches Wegovy Weight-Loss Pill in UAE

The Emirates Drug Establishment said this week that it had approved Novo Nordisk's once-daily tablet. Novo Nordisk Novo Nordisk NOVO.B -2.54 %decrease; red dow...

Nasdaq 2d

Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down

Key Points VK2735 is being developed in both subcutaneous and oral forms, and upcoming Phase 1 maintenance trial results are a major catalyst. VK2735 may offe...

The Motley Fool 3d

Lexicon Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Director — Dr. Mike Exton Senior Vice Presid...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.